Logo image of HOOK

HOOKIPA PHARMA INC (HOOK) Stock Fundamental Analysis

NASDAQ:HOOK - Nasdaq - US43906K2096 - Common Stock - Currency: USD

1.29  -0.01 (-1.15%)

Fundamental Rating

3

Overall HOOK gets a fundamental rating of 3 out of 10. We evaluated HOOK against 557 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for HOOK as it has an excellent financial health rating, but there are worries on the profitability. HOOK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

HOOK had negative earnings in the past year.
HOOK had a negative operating cash flow in the past year.
In the past 5 years HOOK always reported negative net income.
HOOK had a negative operating cash flow in each of the past 5 years.
HOOK Yearly Net Income VS EBIT VS OCF VS FCFHOOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

With a Return On Assets value of -119.68%, HOOK is not doing good in the industry: 80.97% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -215.12%, HOOK is doing worse than 68.94% of the companies in the same industry.
Industry RankSector Rank
ROA -119.68%
ROE -215.12%
ROIC N/A
ROA(3y)-47.11%
ROA(5y)-44.97%
ROE(3y)-79.69%
ROE(5y)-70.35%
ROIC(3y)N/A
ROIC(5y)N/A
HOOK Yearly ROA, ROE, ROICHOOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

HOOK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HOOK Yearly Profit, Operating, Gross MarginsHOOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

More info and screens

7

2. Health

2.1 Basic Checks

HOOK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HOOK remains at a similar level compared to 1 year ago.
HOOK has less shares outstanding than it did 5 years ago.
HOOK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HOOK Yearly Shares OutstandingHOOK Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
HOOK Yearly Total Debt VS Total AssetsHOOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

HOOK has an Altman-Z score of -12.47. This is a bad value and indicates that HOOK is not financially healthy and even has some risk of bankruptcy.
HOOK has a worse Altman-Z score (-12.47) than 77.92% of its industry peers.
HOOK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.47
ROIC/WACCN/A
WACC8.72%
HOOK Yearly LT Debt VS Equity VS FCFHOOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 3.61 indicates that HOOK has no problem at all paying its short term obligations.
HOOK has a Current ratio (3.61) which is in line with its industry peers.
HOOK has a Quick Ratio of 3.61. This indicates that HOOK is financially healthy and has no problem in meeting its short term obligations.
HOOK has a Quick ratio (3.61) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.61
Quick Ratio 3.61
HOOK Yearly Current Assets VS Current LiabilitesHOOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for HOOK have decreased strongly by -16.80% in the last year.
The Revenue for HOOK has decreased by -82.54% in the past year. This is quite bad
HOOK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.77% yearly.
EPS 1Y (TTM)-16.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.82%
Revenue 1Y (TTM)-82.54%
Revenue growth 3Y33.55%
Revenue growth 5Y29.77%
Sales Q2Q%-94.52%

3.2 Future

The Earnings Per Share is expected to grow by 8.32% on average over the next years. This is quite good.
Based on estimates for the next years, HOOK will show a very negative growth in Revenue. The Revenue will decrease by -16.44% on average per year.
EPS Next Y24.26%
EPS Next 2Y20.93%
EPS Next 3Y16.86%
EPS Next 5Y8.32%
Revenue Next Year-49.08%
Revenue Next 2Y-85.73%
Revenue Next 3Y-41.16%
Revenue Next 5Y-16.44%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HOOK Yearly Revenue VS EstimatesHOOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10M 20M 30M 40M 50M
HOOK Yearly EPS VS EstimatesHOOK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HOOK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HOOK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HOOK Price Earnings VS Forward Price EarningsHOOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HOOK Per share dataHOOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

A more expensive valuation may be justified as HOOK's earnings are expected to grow with 16.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.93%
EPS Next 3Y16.86%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HOOK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HOOKIPA PHARMA INC

NASDAQ:HOOK (6/20/2025, 8:00:02 PM)

1.29

-0.01 (-1.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-06 2025-08-06
Inst Owners53.37%
Inst Owner Change-7.94%
Ins Owners0.05%
Ins Owner Change0%
Market Cap15.73M
Analysts45.71
Price Target29.07 (2153.49%)
Short Float %1.79%
Short Ratio1.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-128.61%
Min EPS beat(2)-241.28%
Max EPS beat(2)-15.95%
EPS beat(4)1
Avg EPS beat(4)-65.15%
Min EPS beat(4)-241.28%
Max EPS beat(4)15.62%
EPS beat(8)3
Avg EPS beat(8)-6.22%
EPS beat(12)6
Avg EPS beat(12)0.49%
EPS beat(16)7
Avg EPS beat(16)-4.9%
Revenue beat(2)0
Avg Revenue beat(2)-60.69%
Min Revenue beat(2)-79.59%
Max Revenue beat(2)-41.79%
Revenue beat(4)0
Avg Revenue beat(4)-57.44%
Min Revenue beat(4)-82.17%
Max Revenue beat(4)-26.23%
Revenue beat(8)3
Avg Revenue beat(8)127.91%
Revenue beat(12)4
Avg Revenue beat(12)79.48%
Revenue beat(16)6
Avg Revenue beat(16)52.08%
PT rev (1m)44.92%
PT rev (3m)15.15%
EPS NQ rev (1m)1.61%
EPS NQ rev (3m)1.61%
EPS NY rev (1m)0%
EPS NY rev (3m)-21.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)29.87%
Revenue NY rev (3m)29.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.68
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)-5.84
EYN/A
EPS(NY)-1.89
Fwd EYN/A
FCF(TTM)-4.34
FCFYN/A
OCF(TTM)-4.33
OCFYN/A
SpS0.77
BVpS2.8
TBVpS2.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -119.68%
ROE -215.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.11%
ROA(5y)-44.97%
ROE(3y)-79.69%
ROE(5y)-70.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.92%
Cap/Sales 1.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.61
Quick Ratio 3.61
Altman-Z -12.47
F-Score2
WACC8.72%
ROIC/WACCN/A
Cap/Depr(3y)87.86%
Cap/Depr(5y)118.36%
Cap/Sales(3y)18.78%
Cap/Sales(5y)27.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.82%
EPS Next Y24.26%
EPS Next 2Y20.93%
EPS Next 3Y16.86%
EPS Next 5Y8.32%
Revenue 1Y (TTM)-82.54%
Revenue growth 3Y33.55%
Revenue growth 5Y29.77%
Sales Q2Q%-94.52%
Revenue Next Year-49.08%
Revenue Next 2Y-85.73%
Revenue Next 3Y-41.16%
Revenue Next 5Y-16.44%
EBIT growth 1Y-50.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-105.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-88.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.69%
OCF growth 3YN/A
OCF growth 5YN/A